Old pharma sees new profit cure in cancer drugs

… have expressed interest in building cancer treatment portfolios through acquisitions.
They … $10 billion acquisition of lung cancer company Stemcentryx, Jazz Pharmaceuticals… , Medivation Inc, a U.S. prostate cancer drug company with a market …